Leggett & Platt Q2 Sales Drop 6%, Withdraws Guidance Amid Somnigroup Acquisition
LEG sits 25% above its 52-week low of $8.32.
Summary
Leggett & Platt's Q2 sales fell 6% to $1B, beating the $982.86M consensus, while adjusted EPS of $0.39 topped estimates of $0.26. However, the company withdrew its full-year 2026 guidance, citing the pending acquisition by Somnigroup and ongoing macroeconomic headwinds. The earnings beat was partly driven by non-recurring items like metal margin expansion and restructuring benefits, which won't repeat. Volume declines reflect weak demand across most end markets, retailer merchandising changes in Adjustable Bed, and the exit of a financially challenged customer in U.S. Spring. This follows the June HSR clearance and July definitive proxy filing for the Somnigroup deal, which remains the dominant narrative. The guidance withdrawal removes a key valuation anchor, leaving the stock tied to deal completion and underlying demand trends.
At the time of this announcement, LEG was trading at $10.44 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $8.32 to $13.00. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.